Sideroxylin is primarily used in research settings for its biological activity, particularly its anti-inflammatory and antioxidant properties. It has shown potential in inhibiting enzymes involved in inflammatory pathways, making it a compound of interest in the development of therapeutic agents for chronic inflammatory diseases. Studies also indicate that sideroxylin may exhibit anticancer activity by inducing apoptosis and suppressing the proliferation of certain tumor cell lines. Additionally, it is investigated for its neuroprotective effects, with possible applications in neurodegenerative disorders such as Alzheimer’s disease. Due to its natural origin and structural profile, it serves as a lead compound in medicinal chemistry for designing derivatives with enhanced bioavailability and potency.